Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

Stein MD, Kenney SR, Anderson BJ, Conti MT, Bailey GL.

J Subst Abuse Treat. 2020 Mar;110:37-41. doi: 10.1016/j.jsat.2019.12.007. Epub 2019 Dec 13.

PMID:
31952626
2.

Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.

Stein MD, Kenney SR, Anderson BJ, Bailey GL.

J Subst Abuse Treat. 2019 Sep;104:144-147. doi: 10.1016/j.jsat.2019.07.006. Epub 2019 Jul 13.

PMID:
31370978
3.

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.

Frost M, Bailey GL, Lintzeris N, Strang J, Dunlop A, Nunes EV, Jansen JB, Frey LC, Weber B, Haber P, Oosman S, Kim S, Tiberg F.

Addiction. 2019 Aug;114(8):1416-1426. doi: 10.1111/add.14636. Epub 2019 Jun 3.

4.

Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.

Stein MD, Conti MT, Herman DS, Anderson BJ, Bailey GL, Noppen DV, Abrantes AM.

Am J Addict. 2019 Jul;28(4):270-276. doi: 10.1111/ajad.12884. Epub 2019 Apr 16.

PMID:
30993833
5.

A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: Evidence for construct validity.

Yang LH, Grivel MM, Anderson B, Bailey GL, Opler M, Wong LY, Stein MD.

J Subst Abuse Treat. 2019 Apr;99:44-51. doi: 10.1016/j.jsat.2019.01.005. Epub 2019 Jan 9.

6.

Expectations about alcohol, cocaine, and benzodiazepine abstinence following inpatient heroin withdrawal management.

Kenney SR, Anderson BJ, Bailey GL, Stein MD.

Am J Addict. 2019 Jan;28(1):36-42. doi: 10.1111/ajad.12834. Epub 2018 Dec 12.

PMID:
30548526
7.

Drug Use-Related Normative Misperceptions and Behaviors Among Persons Seeking Heroin Withdrawal Management.

Kenney SR, Anderson BJ, Bailey GL, Stein MD.

J Addict Med. 2019 May/Jun;13(3):215-219. doi: 10.1097/ADM.0000000000000482.

PMID:
30461441
8.

Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management.

Kenney SR, Anderson BJ, Bailey GL, Stein MD.

J Subst Abuse Treat. 2018 Nov;94:55-59. doi: 10.1016/j.jsat.2018.08.011. Epub 2018 Aug 28.

9.

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Frost M, Tiberg F, Linden M, Sheldon B, Oosman S, Peterson S, Chen M, Kim S.

JAMA Intern Med. 2018 Jun 1;178(6):764-773. doi: 10.1001/jamainternmed.2018.1052.

10.

Loaded: Gun involvement among opioid users.

Stein MD, Kenney SR, Anderson BJ, Bailey GL.

Drug Alcohol Depend. 2018 Jun 1;187:205-211. doi: 10.1016/j.drugalcdep.2018.03.015. Epub 2018 Apr 16.

11.

Expected and actual fentanyl exposure among persons seeking opioid withdrawal management.

Kenney SR, Anderson BJ, Conti MT, Bailey GL, Stein MD.

J Subst Abuse Treat. 2018 Mar;86:65-69. doi: 10.1016/j.jsat.2018.01.005. Epub 2018 Jan 4.

12.

Factors associated with naloxone administration in an opioid dependent sample.

Kenney SR, Anderson BJ, Bailey GL, Stein MD.

J Subst Abuse Treat. 2018 Jan;84:17-20. doi: 10.1016/j.jsat.2017.10.008. Epub 2017 Oct 18.

13.

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J.

Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.

14.

The overlap of sleep disturbance and depression in primary care patients treated with buprenorphine.

Garnaat SL, Weisberg RB, Uebelacker LA, Herman DS, Bailey GL, Anderson BJ, Sharkey KM, Stein MD.

Subst Abus. 2017 Oct-Dec;38(4):450-454. doi: 10.1080/08897077.2017.1361498. Epub 2017 Sep 13.

PMID:
28901836
15.

Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification.

Bozinoff N, Anderson BJ, Bailey GL, Stein MD.

J Addict Med. 2018 Jan/Feb;12(1):19-23. doi: 10.1097/ADM.0000000000000355.

16.

Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder.

Stein MD, Conti MT, Kenney S, Anderson BJ, Flori JN, Risi MM, Bailey GL.

Drug Alcohol Depend. 2017 Oct 1;179:325-329. doi: 10.1016/j.drugalcdep.2017.07.007. Epub 2017 Aug 5.

17.

Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder.

Stein MD, Flori JN, Risi MM, Conti MT, Anderson BJ, Bailey GL.

Subst Abus. 2017 Oct-Dec;38(4):389-393. doi: 10.1080/08897077.2017.1353570. Epub 2017 Jul 10.

18.

Broken lives: Fights, fractures, and motor vehicle accidents among heroin users entering detoxification.

Stein MD, Anderson BJ, Bailey GL.

Drug Alcohol Depend. 2017 Aug 1;177:194-198. doi: 10.1016/j.drugalcdep.2017.04.009. Epub 2017 Jun 6.

19.

The relationship between diversion-related attitudes and sharing and selling buprenorphine.

Kenney SR, Anderson BJ, Bailey GL, Stein MD.

J Subst Abuse Treat. 2017 Jul;78:43-47. doi: 10.1016/j.jsat.2017.04.017. Epub 2017 Apr 27.

PMID:
28554602
20.

Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.

Kenney SR, Bailey GL, Anderson BJ, Stein MD.

Addict Behav. 2017 Oct;73:124-128. doi: 10.1016/j.addbeh.2017.05.009. Epub 2017 May 9.

21.

Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.

Stein MD, Anderson BJ, Kenney SR, Bailey GL.

J Subst Abuse Treat. 2017 Jun;77:67-71. doi: 10.1016/j.jsat.2017.03.002. Epub 2017 Mar 9.

22.

Perceived need for depression treatment among persons entering inpatient opioid detoxification.

Stein MD, Santiago Rivera OJ, Anderson BJ, Bailey GL.

Am J Addict. 2017 Jun;26(4):395-399. doi: 10.1111/ajad.12554. Epub 2017 Apr 28.

23.

Knowledge, past use, and willingness to start medication-assisted treatment among persons undergoing alcohol detoxification.

Stein MD, Flori JN, Blevins CE, Conti MT, Anderson BJ, Bailey GL.

Am J Addict. 2017 Mar;26(2):118-121. doi: 10.1111/ajad.12510.

PMID:
28230332
24.

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.

Lee JD, Nunes EV, Mpa PN, Bailey GL, Brigham GS, Cohen AJ, Fishman M, Ling W, Lindblad R, Shmueli-Blumberg D, Stablein D, May J, Salazar D, Liu D, Rotrosen J.

Contemp Clin Trials. 2016 Sep;50:253-64. doi: 10.1016/j.cct.2016.08.004. Epub 2016 Aug 10.

25.

Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.

Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL.

J Subst Abuse Treat. 2016 Sep;68:57-61. doi: 10.1016/j.jsat.2016.06.008. Epub 2016 Jun 16.

26.

Pilot Randomized Trial of Collaborative Behavioral Treatment for Chronic Pain and Depression in Persons Living with HIV/AIDS.

Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Garnaat SL, Stein MD.

AIDS Behav. 2016 Aug;20(8):1675-81. doi: 10.1007/s10461-016-1397-7.

27.

Linkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification.

Stein MD, Risi MM, Bailey GL, Anderson BJ.

J Subst Abuse Treat. 2016 May;64:44-6. doi: 10.1016/j.jsat.2016.01.007. Epub 2016 Feb 23.

28.

Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.

Murphy SM, Campbell AN, Ghitza UE, Kyle TL, Bailey GL, Nunes EV, Polsky D.

Drug Alcohol Depend. 2016 Apr 1;161:119-26. doi: 10.1016/j.drugalcdep.2016.01.021. Epub 2016 Jan 30.

29.

Gender Differences in the Life Concerns of Persons Seeking Alcohol Detoxification.

Stein MD, Risi MM, Flori JN, Conti MT, Anderson BJ, Bailey GL.

J Subst Abuse Treat. 2016 Apr;63:34-8. doi: 10.1016/j.jsat.2015.12.005. Epub 2015 Dec 28.

30.

An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Stein MD, Caviness C, Grimone K, Audet D, Anderson BJ, Bailey GL.

Nicotine Tob Res. 2016 May;18(5):1157-62. doi: 10.1093/ntr/ntv267. Epub 2015 Dec 28.

31.

Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Stein MD, Anderson BJ, Bailey GL.

J Subst Abuse Treat. 2015 Dec;59:99-103. doi: 10.1016/j.jsat.2015.07.002. Epub 2015 Jul 14.

32.

Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD.

Pain Med. 2015 Oct;16(10):1870-81. doi: 10.1111/pme.12799. Epub 2015 Jun 27.

33.

Chronic pain and depression among primary care patients treated with buprenorphine.

Stein MD, Herman DS, Bailey GL, Straus J, Anderson BJ, Uebelacker LA, Weisberg RB.

J Gen Intern Med. 2015 Jul;30(7):935-41. doi: 10.1007/s11606-015-3212-y. Epub 2015 Feb 13.

34.

The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study.

Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML.

Subst Abus. 2015;36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11.

35.

Gender-based Outcomes and Acceptability of a Computer-assisted Psychosocial Intervention for Substance Use Disorders.

Campbell AN, Nunes EV, Pavlicova M, Hatch-Maillette M, Hu MC, Bailey GL, Sugarman DE, Miele GM, Rieckmann T, Shores-Wilson K, Turrigiano E, Greenfield SF.

J Subst Abuse Treat. 2015 Jun;53:9-15. doi: 10.1016/j.jsat.2014.12.006. Epub 2014 Dec 30.

36.

Comparing the life concerns of prescription opioid and heroin users.

Stein MD, Anderson BJ, Thurmond P, Bailey GL.

J Subst Abuse Treat. 2015 Jan;48(1):43-8. doi: 10.1016/j.jsat.2014.07.001. Epub 2014 Jul 11.

37.

Group therapy for women with substance use disorders: results from the Women's Recovery Group Study.

Greenfield SF, Sugarman DE, Freid CM, Bailey GL, Crisafulli MA, Kaufman JS, Wigderson S, Connery HS, Rodolico J, Morgan-Lopez AA, Fitzmaurice GM.

Drug Alcohol Depend. 2014 Sep 1;142:245-53. doi: 10.1016/j.drugalcdep.2014.06.035. Epub 2014 Jul 4.

38.

Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study.

Greenfield SF, Crisafulli MA, Kaufman JS, Freid CM, Bailey GL, Connery HS, Rapoza M, Rodolico J.

Am J Addict. 2014 May-Jun;23(3):197-204. doi: 10.1111/j.1521-0391.2014.12099.x.

39.

Looking for the uninsured in Massachusetts? Check opioid dependent persons seeking detoxification.

Stein MD, Bailey GL, Thurmond P, Paull N.

Drug Alcohol Depend. 2014 Mar 1;136:166-9. doi: 10.1016/j.drugalcdep.2013.12.016. Epub 2014 Jan 3.

40.

Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.

Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL.

Addiction. 2013 Dec;108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18.

41.

Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.

Bailey GL, Herman DS, Stein MD.

J Subst Abuse Treat. 2013 Sep;45(3):302-5. doi: 10.1016/j.jsat.2013.04.002. Epub 2013 Jun 18.

42.

Outcomes of tongue-pressure strength and accuracy training for dysphagia following acquired brain injury.

Steele CM, Bailey GL, Polacco RE, Hori SF, Molfenter SM, Oshalla M, Yeates EM.

Int J Speech Lang Pathol. 2013 Oct;15(5):492-502. doi: 10.3109/17549507.2012.752864. Epub 2013 Jan 22.

43.

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.

Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR.

Contemp Clin Trials. 2012 Mar;33(2):386-95. doi: 10.1016/j.cct.2011.11.001. Epub 2011 Nov 9.

44.

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.

Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D.

J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. doi: 10.1016/j.jaac.2011.06.010. Epub 2011 Aug 4.

45.

The relationship between hyoid and laryngeal displacement and swallowing impairment.

Steele CM, Bailey GL, Chau T, Molfenter SM, Oshalla M, Waito AA, Zoratto DC.

Clin Otolaryngol. 2011 Feb;36(1):30-6. doi: 10.1111/j.1749-4486.2010.02219.x.

46.

Pressure profile similarities between tongue resistance training tasks and liquid swallows.

Steele CM, Bailey GL, Molfenter SM, Yeates EM, Grace-Martin K.

J Rehabil Res Dev. 2010;47(7):651-60.

47.

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.

Ling W, Casadonte P, Bigelow G, Kampman KM, Patkar A, Bailey GL, Rosenthal RN, Beebe KL.

JAMA. 2010 Oct 13;304(14):1576-83. doi: 10.1001/jama.2010.1427.

PMID:
20940383
48.

Voice-quality abnormalities as a sign of dysphagia: validation against acoustic and videofluoroscopic data.

Waito A, Bailey GL, Molfenter SM, Zoratto DC, Steele CM.

Dysphagia. 2011 Jun;26(2):125-34. doi: 10.1007/s00455-010-9282-4. Epub 2010 May 8.

PMID:
20454806
49.

Methods of recruiting adolescents with psychiatric and substance use disorders for a clinical trial.

Jaffee WB, Bailey GL, Lohman M, Riggs P, McDonald L, Weiss RD.

Am J Drug Alcohol Abuse. 2009;35(5):381-4. doi: 10.1080/00952990903150860.

50.

Tongue pressure modulation during swallowing: water versus nectar-thick liquids.

Steele CM, Bailey GL, Molfenter SM.

J Speech Lang Hear Res. 2010 Apr;53(2):273-83. doi: 10.1044/1092-4388(2009/09-0076). Epub 2009 Dec 14.

PMID:
20008678

Supplemental Content

Loading ...
Support Center